Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Chemother ; 19(5): 514-8, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18073150

RESUMO

The in vitro activity of the peptide IB-367, alone or combined with either fluconazole (FLU) or amphotericin B (AMB), was investigated against 25 Candida isolates belonging to five species. IB-367 minimum inhibitory concentrations (MICs) ranged from 2.0 to 32 microg/ml and it was active against both FLU-susceptible and - resistant isolates. A rapid fungicidal activity was observed. Synergism was documented in 41.6% and 44% of IB-367/FLU and IB-367/AMB interactions, respectively. Antagonism was never observed. The broad antifungal activity and the positive interactions with AMB and FLU suggest that IB-367 represents a promising candidate against infections due to Candida spp.


Assuntos
Antifúngicos/farmacologia , Candida/efeitos dos fármacos , Peptídeos/farmacologia , Anfotericina B/administração & dosagem , Peptídeos Catiônicos Antimicrobianos , Candidíase/tratamento farmacológico , Farmacorresistência Fúngica , Sinergismo Farmacológico , Quimioterapia Combinada , Fluconazol/administração & dosagem , Humanos , Técnicas In Vitro , Testes de Sensibilidade Microbiana
2.
Drug Deliv ; 11(6): 341-4, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15736828

RESUMO

Cisplatin an antineoplastic medicine, was incorporated into a silica gel received by the sol-gel method. Various techniques of trapping an active substance in gel were applied: at the stage of sol creation--by the predoping method--and already upon receipt of hard xerogel--the postdoping method. Further, the research aimed at the determination of the dynamics of cisplatin release from sol-gel processed silica xerogel to the water phase. Based on the achieved results, we may state that the sol-gel method is useful for trapping a medicine like cisplatin in silica gel and gives repeatable results with regard to medicine release from the pores of the so-established matrix. The postdoping method appeared to be more beneficial, because the gained gel's active substance is released almost entirely (94-96%). The time of release was 3 days.


Assuntos
Cisplatino/farmacocinética , Transição de Fase , Dióxido de Silício/farmacocinética , Porosidade , Sílica Gel
3.
Gut ; 52(6): 874-8, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12740345

RESUMO

BACKGROUND: Postoperative morbidity in patients with obstructive jaundice remains high because of increased susceptibility to endotoxin and the inflammatory cascade. AIMS: An experimental study was designed to investigate the efficacy of protegrin peptide IB-367, an antimicrobial positively charged peptide, in neutralising Escherichia coli 0111:B4 lipopolysaccharide (LPS) in bile duct ligated rats. METHODS: Adult male Wistar rats were injected intraperitoneally with 2 mg/kg E coli 0111:B4 LPS one week after sham operation or bile duct ligation (BDL). Six groups were studied: sham with placebo, sham with 120 mg/kg tazobactam-piperacillin (TZP), sham with 1 mg/kg IB-367, BDL with placebo, BDL with 120 mg/kg TZP, and BDL with 1 mg/kg IB-367. RESULTS: Main outcome measures were: endotoxin and tumour necrosis factor alpha (TNF-alpha) concentrations in plasma, evidence of bacterial translocation in blood and peritoneum, and lethality. After LPS, TNF-alpha plasma levels were significantly higher in BDL rats compared with sham operated animals. IB-367 caused a significant reduction in plasma endotoxin and TNF-alpha concentrations compared with placebo and TZP treated groups. In contrast, both TZP and IB-367 significantly reduced bacterial growth compared with saline treatment. Finally, LPS induced 60% and 55% lethality in BDL placebo and TZP treated rats and no lethality in sham operated rats, while only IB-367 significantly reduced lethality to 10%. CONCLUSIONS: By virtue of its dual antimicrobial and antiendotoxin properties, IB-367 could be an interesting compound to inhibit bacterial translocation and endotoxin release in obstructive jaundice.


Assuntos
Colestase/cirurgia , Endotoxemia/prevenção & controle , Infecções por Escherichia coli/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Proteínas/uso terapêutico , Animais , Anti-Infecciosos/uso terapêutico , Peptídeos Catiônicos Antimicrobianos , Translocação Bacteriana/efeitos dos fármacos , Ductos Biliares/cirurgia , Modelos Animais de Doenças , Ligadura , Lipopolissacarídeos/toxicidade , Masculino , Peptídeos , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/metabolismo
6.
Exp Pathol ; 28(4): 215-23, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-3830741

RESUMO

It was the aim of our investigations to increase the antitumor activity of cyclophosphamide. Therefore we applied a combined treatment with silatranes and isoniazid in relation 1:20:1. The effects were directed against a transplantable sarcoma 180. The parablastomatous invasive zone and the regional lymph nodes draining an implanted tumor were taken for the histochemical and morphological studies. The doses ranged from 50 to 175 mg of body mass. The combined derivatives inhibited tumor growth by 70% in relation to the control. The authors connect the limitation of tumor progression in the applied experimental model in mice with the active response of T dependent zone of the regional lymph nodes, the rebuilding of stroma within the borderline invasive zone and the changes within the composition of cellular immune response of the peritumor tissue.


Assuntos
Compostos Bicíclicos Heterocíclicos com Pontes , Compostos Bicíclicos com Pontes/uso terapêutico , Hidrocarbonetos Aromáticos com Pontes/uso terapêutico , Ciclofosfamida/uso terapêutico , Isoniazida/uso terapêutico , Compostos de Organossilício , Sarcoma 180/tratamento farmacológico , Silício/uso terapêutico , Animais , Compostos Bicíclicos com Pontes/administração & dosagem , Ciclofosfamida/administração & dosagem , Combinação de Medicamentos , Feminino , Isoniazida/administração & dosagem , Linfonodos/patologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Invasividade Neoplásica , Sarcoma 180/patologia , Silício/administração & dosagem
7.
Polim Med ; 11(2): 79-82, 1981.
Artigo em Polonês | MEDLINE | ID: mdl-7339595

RESUMO

The ethoxypolisiloxan (EPS) oil glycol emulsion in radiology has been proved to have the LD50 value of 14,5 g/kg. This means that this emulsion is low toxic. The antifoaming efficiency of EPS emulsion was compared with that of Endo-Paractol. It was found that the effects comparable what proves the value of the EPS emulsion, the more so that the production costs are relatively low. The radiological clinical investigation confirmed the usefulness of the X-ray contrast in examinations of the gastrointestinal treat.


Assuntos
Meios de Contraste/toxicidade , Silicones , Siloxanas , Avaliação de Medicamentos , Emulsões , Óleos , Siloxanas/administração & dosagem , Siloxanas/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA